In summary, adipocyte removal of triglycerides is independently associated with an atherogenic hypertriglyceridemia/hyperapoB profile in 2 independent populations and explains as much as 20% of the variation in the circulating levels of apoB and triglycerides between subjects. The gene discussed is APOB; the disease is hypertriglyceridemia.